Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)
NCT00163319
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Ciclesonide
Sponsor
AstraZeneca